US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALPHA COGNITION INC

9.11

-0.1050-1.14%

Post-market: 9.110.00000.00%19:14 EDT

Volume:43.51K

Turnover:402.28K

Market Cap:145.86M

PE:-7.68

High:9.34

Open:9.16

Low:8.96

Close:9.21

Loading ...

Overview Company News Filings

Alpha Cognition Shares up 10.9% After Co Commercially Launches Alzheimer’s Disease Treatment

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE- Block, KBR, Sarepta Therapeutics

Alpha Cognition Launches Zunveyl for Treating Alzheimer's Disease; Shares Up Pre-Bell

MT Newswires Live

Alpha Cognition : Announces Commercial Launch of Zunveyl (Benzgalantamine) for Treatment of Mild to Moderate Alzheimer's Disease

THOMSON REUTERS

Alpha Cognition Announces the Commercial Launch of ZUNVEYL (Benzgalantamine) for the Treatment of Mild to Moderate Alzheimer’s Disease

BUZZ-U.S. STOCKS ON THE MOVE- Tesla, Block, Alibaba Group

HC Wainwright Initiates Alpha Cognition at Buy With $20 Price Target

MT Newswires Live

BUZZ-H.C. Wainwright starts coverage on Alpha Cognition, bullish on next-gen Alzheimer's therapy

Alpha Cognition Inc : H.c. Wainwright Initiates Coverage With Buy Rating; Price Target $20

THOMSON REUTERS

Alpha Cognition Inc. Common Stock (ACOG): A Bull Case Theory

Alpha Cognition secures additional patent for Zunveyl from USPTO

BRIEF-Alpha Cognition Secures Additional U.S. Patent For Zunveyl (Benzgalantamine)

Alpha Cognition Secures Additional U.S. Patent for Zunveyl (Benzgalantamine) in the Treatment of Mild to Moderate Alzheimer’s Disease

THOMSON REUTERS

Alpha Cognition Secures Additional U.S. Patent for ZUNVEYL (benzgalantamine) in the Treatment of Mild to Moderate Alzheimer’s disease

Stonegate Capital Partners Initiates Coverage on Alpha Cognition Inc. (ACOG)

Myriad Genetics Introduces Online Prenatal Genetic Testing Resource

OTC Markets Group Announces Quarterly Index Performance and Rebalancing

Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology

Alpha Cognition makes strategic personnel appointments to support ZUNVEYL launch

Alpha Cognition Expands Commercial and Medical Teams with Key Leadership Hires to Support the Launch of ZUNVEYL

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ACOG/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACOG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACOG\",,,,,undefined,":{"symbol":"ACOG","market":"US","secType":"STK","nameCN":"ALPHA COGNITION INC","latestPrice":9.105,"timestamp":1751054400000,"preClose":9.21,"halted":0,"volume":43509,"hourTrading":{"tag":"盘后","latestPrice":9.105,"preClose":9.105,"latestTime":"19:14 EDT","volume":16,"amount":143.955,"timestamp":1751066096830},"delay":0,"floatShares":9331035,"shares":16019787,"eps":-1.185811,"marketStatus":"Market Closed","change":-0.105,"latestTime":"06-27 16:00:00 EDT","open":9.16,"high":9.34,"low":8.96,"amount":402278.7503,"amplitude":0.04126,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.185811,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1751270400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":9.21,"preHourTrading":{"tag":"盘前","latestPrice":9.3,"preClose":9.21,"latestTime":"08:32 EDT","volume":140,"amount":1302,"timestamp":1751027566708},"postHourTrading":{"tag":"盘后","latestPrice":9.105,"preClose":9.105,"latestTime":"19:14 EDT","volume":16,"amount":143.955,"timestamp":1751066096830},"volumeRatio":0.551890991678186},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACOG\",,,,,undefined,":{"symbol":"ACOG","floatShares":9331035,"roa":"-26.72%","roe":"-56.79%","lyrEps":-2.019472,"volumeRatio":0.551890991678186,"shares":16019787,"dividePrice":0,"high":9.34,"amplitude":0.04126,"preClose":9.21,"low":8.96,"week52Low":3.75,"pbRate":"3.57","psRate":"49.80","week52High":11.4,"institutionHeld":0,"latestPrice":9.105,"eps":-1.185811,"divideRate":0,"volume":43509,"delay":0,"ttmEps":-1.185811,"open":9.16,"prevYearClose":5.89,"prevWeekClose":9.16,"prevMonthClose":9.33,"prevQuarterClose":5.06,"fiveDayClose":9.16,"twentyDayClose":10.09,"sixtyDayClose":4.85},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACOG\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520779976","title":"Alpha Cognition Shares up 10.9% After Co Commercially Launches Alzheimer’s Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2520779976","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520779976?lang=en_us&edition=fundamental","pubTime":"2025-03-18 21:33","pubTimestamp":1742304787,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q102Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2520671197","title":"BUZZ-U.S. STOCKS ON THE MOVE- Block, KBR, Sarepta Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2520671197","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520671197?lang=en_us&edition=fundamental","pubTime":"2025-03-18 21:05","pubTimestamp":1742303127,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Block, KBR, Sarepta TherapeuticsEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nL6N3Q10FU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0264606111.USD","HROW","LU1734074674.USD","LCID","SGXZ31699556.SGD","LU1429558221.USD","LU1880383366.USD","LU1629891620.HKD","LU0327786744.USD","LU1048588211.SGD","SG9999000418.SGD","SG9999000459.SGD","ETR","LU0708995583.HKD","LU0572940350.SGD","IE00BD4GTT62.SGD","SRPT","01698","ACOG","HBBD.SI","LU0048597586.USD","BK4571","SG9999015986.USD","TME","89988","LU1629966141.USD","CNR","SG9999001846.SGD","KBR","LU0516422952.EUR","SG9999001903.USD","LU1105468828.SGD","HK0000306701.USD","LU0449515922.USD","XYZ","BE","HTCD.SI","BTU","80700","GENI","IE00B1XK9C88.USD","LU0173614495.USD","TSYW.SI"],"gpt_icon":1},{"id":"2520676712","title":"Alpha Cognition Launches Zunveyl for Treating Alzheimer's Disease; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2520676712","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520676712?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:50","pubTimestamp":1742302215,"startTime":"0","endTime":"0","summary":"Alpha Cognition (ACOG) said Tuesday it has commercially launched Zunveyl for the treatment of mild to moderate Alzheimer's disease.The company said the official commercial launch provides patients wit","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ACOG","BK4139"],"gpt_icon":0},{"id":"2520675188","title":"Alpha Cognition : Announces Commercial Launch of Zunveyl (Benzgalantamine) for Treatment of Mild to Moderate Alzheimer's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2520675188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520675188?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:39","pubTimestamp":1742301560,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q115P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2520675715","title":"Alpha Cognition Announces the Commercial Launch of ZUNVEYL (Benzgalantamine) for the Treatment of Mild to Moderate Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2520675715","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520675715?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:30","pubTimestamp":1742301000,"startTime":"0","endTime":"0","summary":"ZUNVEYL is the first oral FDA-approved treatment for Alzheimer’s disease in the past decade. 32 person sales team hired to cover the $2 billion Long-Term-Care market. All launch activities delivered on-time and on-budget, positioning ZUNVEYL for success. VANCOUVER, British Columbia & DALLAS, March 18, 2025----Alpha Cognition Inc. , a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced the official commercial launch of ZUNVEYL, a new treatment for mild to moderate Alzheimer’s disease. This milestone marks a major step forward in the company’s mission to provide innovative and accessible solutions for patients and caregivers — and to deliver new hope to the millions impacted by Alzheimer’s.ZUNVEYL  is a twice-daily treatment designed to address the cognitive symptoms of mild-to-moderate Alzheimer’s disease. By enhancing cholinergic function in the brain, ZUNVEYL supports memory, le","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alpha-cognition-announces-commercial-launch-123000099.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Alpha Cognition Announces the Commercial Launch of ZUNVEYL (Benzgalantamine) for the Treatment of Mild to Moderate Alzheimer’s Disease","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACOG","BK4139"],"gpt_icon":0},{"id":"2520062434","title":"BUZZ-U.S. STOCKS ON THE MOVE- Tesla, Block, Alibaba Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2520062434","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520062434?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:41","pubTimestamp":1742298095,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Block, Alibaba Group Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nL6N3Q10GD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4511","ETR","LU0315178854.USD","HBBD.SI","SG9999014880.SGD","09988","TSYW.SI","LU0359202008.SGD","LU0348783662.USD","TME","GENI","LU1725190679.HKD","IE00B19Z3B42.SGD","IE00BGV7N243.SGD","LU2756315664.SGD","IE00B97KM107.HKD","HROW","BABA","LU0259732245.USD","LU0633140727.USD","IE0002270589.USD","IE0034224299.USD","LU2360107168.USD","IE00BZ08YS42.EUR","LU0648948544.HKD","BK4535","LU0163747925.USD","80700","LU0633140560.USD","89988","IE00BZ08YR35.GBP","BK1588","LU0345770993.USD","TSLA","01698","LCID","LU2471134796.USD","ACOG","HTCD.SI","LU0261950983.USD","LU2097828631.EUR","LU0588545904.SGD","BK4077","XYZ","LU0327786744.USD","LU1066053197.SGD","LU0049853897.USD"],"gpt_icon":1},{"id":"2520670623","title":"HC Wainwright Initiates Alpha Cognition at Buy With $20 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2520670623","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520670623?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:02","pubTimestamp":1742295762,"startTime":"0","endTime":"0","summary":"HC Wainwright Initiates Alpha Cognition at Buy With $20 Price Target","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ACOG"],"gpt_icon":0},{"id":"2520628128","title":"BUZZ-H.C. Wainwright starts coverage on Alpha Cognition, bullish on next-gen Alzheimer's therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2520628128","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520628128?lang=en_us&edition=fundamental","pubTime":"2025-03-18 18:58","pubTimestamp":1742295512,"startTime":"0","endTime":"0","summary":"BUZZ-H.C. Wainwright starts coverage on Alpha Cognition, bullish on next-gen Alzheimer's therapy** Brokerage H.C. Wainwright starts coverage on drug developer Alpha Cognition Inc ACOG.O with \"buy\" rating and $20 PT, a 251.5% upside to the stock's last close** Says co's Alzheimer's disease drug Zunveyl, which is a \"next-generation symptomatic therapy\" has been shown to have a \"very low rate of GI side effects \" compared to 30-40% with existing cholinesterase inhibitors, and \"eliminate sleep disturbances\"** Says co has a \"finely tuned sales force\" that is expected to cover 80% of the long-term care market in the US, with 88% of physicians indicating they would prescribe Zunveyl** Co has a \"considerable long-term promise\" that is not reflected in its current stock price, which has been \"range-bound\" due to its relatively unknown status among US investors - brokerage** Estimates Zunveyl to generate $540 mln in peak annual sales in the US by the late 2030s** Stock fell ~53% in 2024  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nL4N3Q10QO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG","BK4139"],"gpt_icon":0},{"id":"2520644049","title":"Alpha Cognition Inc : H.c. Wainwright Initiates Coverage With Buy Rating; Price Target $20","url":"https://stock-news.laohu8.com/highlight/detail?id=2520644049","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520644049?lang=en_us&edition=fundamental","pubTime":"2025-03-18 18:23","pubTimestamp":1742293382,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q10SD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2517914790","title":"Alpha Cognition Inc. Common Stock (ACOG): A Bull Case Theory","url":"https://stock-news.laohu8.com/highlight/detail?id=2517914790","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517914790?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:35","pubTimestamp":1741181723,"startTime":"0","endTime":"0","summary":"We came across abullish thesison Alpha Cognition Inc. Common Stock  on Twitter by BullishDoctor. In this article, we will summarize the bulls’ thesis on ACOG. Alpha Cognition Inc. Common Stock 's share was trading at $5.75 as of March 4th. ACOG’s forward P/E was 16.05 according to Yahoo Finance.A supportive smile shared between a care facility staff member and a resident with Alzheimer's or Dementia.Alpha Cognition Inc. Common Stock  is not on our list of the30 Most Popular Stocks Among Hedge Funds. As per our database, 10 hedge fund portfolios held ACOG at the end of the fourth quarter which was 0 in the previous quarter. While we acknowledge the risk and potential of ACOG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than ACOG but that trades at less than 5 times its earnings, check out our report about the ch","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alpha-cognition-inc-common-stock-133523406.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LTC","ACOG","BK4225","BK4203","BK4588","BK4139","BK4585"],"gpt_icon":0},{"id":"2510372350","title":"Alpha Cognition secures additional patent for Zunveyl from USPTO","url":"https://stock-news.laohu8.com/highlight/detail?id=2510372350","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510372350?lang=en_us&edition=fundamental","pubTime":"2025-02-12 21:42","pubTimestamp":1739367752,"startTime":"0","endTime":"0","summary":"Alpha Cognition (ACOG) announced that the United States Patent and Trademark Office has granted a new patent titled “Coated Tablets for pH-Dependen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alpha-cognition-secures-additional-patent-for-zunveyl-from-uspto?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alpha-cognition-secures-additional-patent-for-zunveyl-from-uspto?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACOG","BK4139"],"gpt_icon":0},{"id":"2510374590","title":"BRIEF-Alpha Cognition Secures Additional U.S. Patent For Zunveyl (Benzgalantamine)","url":"https://stock-news.laohu8.com/highlight/detail?id=2510374590","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510374590?lang=en_us&edition=fundamental","pubTime":"2025-02-12 21:35","pubTimestamp":1739367301,"startTime":"0","endTime":"0","summary":"BRIEF-Alpha Cognition Secures Additional U.S. Patent For Zunveyl (Benzgalantamine) Feb 12 (Reuters) - Alpha Cognition ACOG.O:ALPHA COGNITION SECURES ADDITIONAL U.S. PATENT FOR ZUNVEYL (BENZGALANTAMINE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P30WU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG","BK4139"],"gpt_icon":0},{"id":"2510237176","title":"Alpha Cognition Secures Additional U.S. Patent for Zunveyl (Benzgalantamine) in the Treatment of Mild to Moderate Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2510237176","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510237176?lang=en_us&edition=fundamental","pubTime":"2025-02-12 21:30","pubTimestamp":1739367017,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P30WU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2510437220","title":"Alpha Cognition Secures Additional U.S. Patent for ZUNVEYL (benzgalantamine) in the Treatment of Mild to Moderate Alzheimer’s disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2510437220","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510437220?lang=en_us&edition=fundamental","pubTime":"2025-02-12 21:30","pubTimestamp":1739367000,"startTime":"0","endTime":"0","summary":"VANCOUVER, February 12, 2025----Alpha Cognition Inc.  , a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that the United States Patent and Trademark Office  has granted a new patent titled \"Coated Tablets for pH-Dependent Release of Benzgalantamine.\". This newly issued patent strengthens Alpha Cognition’s intellectual property portfolio by covering the composition of tablet formulations of benzgalantamine, further reinforcing the Company’s existing patent protections. With this approval, ZUNVEYL has patent protection in the United States through 2044, supporting the Company’s long-term growth strategy as it prepares for commercialization.Alpha Cognition Inc. is a clinical stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and Cognitive Impairment with mild Traumatic Brain Injury , for which there are currently no app","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alpha-cognition-secures-additional-u-133000849.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACOG","ACI","BK4113","BK4139"],"gpt_icon":0},{"id":"2507675845","title":"Stonegate Capital Partners Initiates Coverage on Alpha Cognition Inc. (ACOG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2507675845","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507675845?lang=en_us&edition=fundamental","pubTime":"2025-01-31 00:05","pubTimestamp":1738253100,"startTime":"0","endTime":"0","summary":"Dallas, Texas-- - Alpha Cognition Inc. : Stonegate Capital Partners initiates their coverage on Alpha Cognition Inc. . Alpha Cognition Inc. reported significant progress in 2024 so far, marked by key financial and corporate milestones. Alpha Cognition received approval for its flagship Alzheimer's therapy ZUNVEYL , successfully raised $4.5M in financing, and completed the necessary preparations for listing on the NASDAQ exchange. These initiatives have positioned the Company to launch ZUNVEYL in 1Q25, with an in place sales force and commercial production already underway.To view the full announcement, including downloadable images, bios, and more, click here.Alpha Cognition is set to launch ZUNVEYL in 1Q25, targeting the long-term care  market, a $2 billion addressable market representing 36% of Alzheimer's prescriptions.ZUNVEYL's prodrug mechanism bypasses GI absorption, significantly reducing common side effects like nausea and insomnia, leading to better patient adherence and impro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/stonegate-capital-partners-initiates-coverage-160500121.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/stonegate-capital-partners-initiates-coverage-160500121.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","MNQmain","ACOG",".IXIC","QQQ","USJW.SI","TSYW.SI","SQQQ","PSQ","BK4585","LTC","TQQQ","NVIW.SI","QID","NQmain","QLD","BK4203","USAW.SI","BK4588","BK4225"],"gpt_icon":0},{"id":"2505134580","title":"Myriad Genetics Introduces Online Prenatal Genetic Testing Resource","url":"https://stock-news.laohu8.com/highlight/detail?id=2505134580","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505134580?lang=en_us&edition=fundamental","pubTime":"2025-01-23 21:30","pubTimestamp":1737639000,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Jan.  23, 2025  (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, has launched a new educational website providing comprehen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/23/3014262/15459/en/Myriad-Genetics-Introduces-Online-Prenatal-Genetic-Testing-Resource.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACOG","MYGN"],"gpt_icon":0},{"id":"2505974521","title":"OTC Markets Group Announces Quarterly Index Performance and Rebalancing","url":"https://stock-news.laohu8.com/highlight/detail?id=2505974521","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505974521?lang=en_us&edition=fundamental","pubTime":"2025-01-22 20:00","pubTimestamp":1737547200,"startTime":"0","endTime":"0","summary":"NEW YORK, Jan. 22, 2025  -- OTC Markets Group Inc. , operator of regulated financial markets for 12,000 U.S. and global securities, today announced the fourth quarter 2024 performance and quarterly rebalancing of the OTCQX and OTCQB indexes, including the OTCQX Canada Index and the OTCQX Dividend Index.The OTCQX Composite Index , a benchmark for the overall OTCQX Best Market, was down 9.8% in Q4 2024. 32 new companies joined the Index while 31 companies were removed. Aduro Clean Technologies  went to NASDAQ on 11/7/2024. Mackenzie Realty Capital  went to NASDAQ on 11/11/2024. Exodus Movement  went to NYSE MKT on 12/18/2024.The OTCQX Billion+ Index , which tracks the performance of $1 billion-plus market cap OTCQX companies was down 10.0% in Q4 2024. 6 new companies joined the Index and 4 companies were removed.The OTCQX Dividend Index , which tracks dividend-paying U.S. and international OTCQX companies, was down 9.6% in Q4 2024. 12 new companies joined the Index, while 9 companies wer","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/otc-markets-group-announces-quarterly-120000883.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ATS","USAW.SI","BK4161","ADUR","MNQmain","BHST","BK4082","BK4112","QLD","TQQQ","BK4160","TSYW.SI","MKZR","SQQQ","TSSI","OTCM","PSQ","BK4023","NQmain","QID","BK4134","BK4183","TZUP","USJW.SI","ACOG","BK4139","BK4137","BSGM","EXOD","NVIW.SI",".IXIC"],"gpt_icon":1},{"id":"2505627334","title":"Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology","url":"https://stock-news.laohu8.com/highlight/detail?id=2505627334","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505627334?lang=en_us&edition=fundamental","pubTime":"2025-01-21 21:30","pubTimestamp":1737466200,"startTime":"0","endTime":"0","summary":"Study showed online screening tool and patient education improved genetic testing completion rate. SALT LAKE CITY, Jan. 21, 2025  -- Myriad Genetics, Inc. , a leader in genetic testing and precision medicine, announced a study revealing that more patients completed hereditary cancer testing when they used an online screening tool and received education about genetic testing. The study was published in Obstetrics & Gynecology  and was highlighted in the American College of Obstetricians and Gynecologists  Daily Bulletin.“These findings further support Myriad’s commitment to provider ease of use and patient access by enabling an always-on tool to drive appropriate patient identification and education, via our Breast Cancer Risk Assessment Program,” said Melissa Gonzales, President of Women’s Health, Myriad Genetics.Myriad’s Breast Cancer Risk Assessment Program features the MyRisk with RiskScore Hereditary Cancer Test, the first and industry-leading hereditary cancer test and polygenic b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/myriad-genetics-announces-hereditary-cancer-133000725.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MYGN","ACOG","BK4139"],"gpt_icon":0},{"id":"2503575308","title":"Alpha Cognition makes strategic personnel appointments to support ZUNVEYL launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2503575308","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503575308?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:50","pubTimestamp":1736862646,"startTime":"0","endTime":"0","summary":"Alpha Cognition (ACOG) announced the strategic appointments of Jen Pesa, Vice President of Commercial; Jack Kelly, Head of Market Access; Rommel Fe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alpha-cognition-makes-strategic-personnel-appointments-to-support-zunveyl-launch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alpha-cognition-makes-strategic-personnel-appointments-to-support-zunveyl-launch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2503573952","title":"Alpha Cognition Expands Commercial and Medical Teams with Key Leadership Hires to Support the Launch of ZUNVEYL","url":"https://stock-news.laohu8.com/highlight/detail?id=2503573952","media":"Business Wire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503573952?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:30","pubTimestamp":1736861400,"startTime":"0","endTime":"0","summary":"VANCOUVER, British Columbia & DALLAS, January 14, 2025----Alpha Cognition Inc.  , a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today announced the strategic appointments of Jen Pesa, Vice President of Commercial; Jack Kelly, Head of Market Access; Rommel Fernandez, Vice President of Corporate Strategy and Operations; and Kurt Grady, Vice President of Medical Affairs. These hires mark significant milestones in building Alpha Cognition’s commercial and medical teams as the company prepares for the upcoming launch of ZUNVEYL, its innovative treatment for mild to moderate Alzheimer’s disease.Dr. Grady has over 30 years of experience in health care, with a strong background in both clinical practice and the life science industry. He possesses broad therapeutic experience and has supported the launch of 9 new pro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alpha-cognition-expands-commercial-medical-133000062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4161","BK4203","BK4225","ACOG","DSI","LTC","BK4588","B","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":49,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACOG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"ACOG","fiscalQuarterEnding":"2025/03","expectedEps":-0.58,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.2},{"market":"US","date":"2025-03-31","symbol":"ACOG","fiscalQuarterEnding":"2024/12","expectedEps":-0.48,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":-0.51}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACOG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACOG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1742356800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACOG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACOG","date":"2025-06-27","current":-12.674691,"percent":0.098039,"low":-14.553188,"twenty":-8.112302,"median":-6.314587,"eighty":-5.6646,"high":-2.141254,"avg":-7.325323,"sd":2.737702,"marketCap":147542238},"quantilePoints":[{"date":"2024-11-15","current":-5.518409,"twenty":-5.518409,"median":-5.518409,"eighty":-3.492116,"marketCap":89218230.86},{"date":"2024-11-22","current":-6.095906,"twenty":-6.0779,"median":-6.040783,"eighty":-5.518409,"marketCap":89580038.69},{"date":"2024-11-29","current":-7.052964,"twenty":-6.126453,"median":-6.040783,"eighty":-5.612398,"marketCap":103759893.65},{"date":"2024-12-06","current":-6.313396,"twenty":-6.313396,"median":-6.095906,"eighty":-5.994414,"marketCap":92879715.89},{"date":"2024-12-13","current":-5.804676,"twenty":-6.309556,"median":-6.047523,"eighty":-5.928174,"marketCap":85395665.51},{"date":"2024-12-20","current":-3.792145,"twenty":-6.289737,"median":-6.03741,"eighty":-5.564347,"marketCap":55788252.01},{"date":"2024-12-27","current":-5.520861,"twenty":-6.27191,"median":-5.988356,"eighty":-5.512882,"marketCap":81220325},{"date":"2025-01-03","current":-6.174218,"twenty":-6.276367,"median":-6.018645,"eighty":-5.517304,"marketCap":90832197},{"date":"2025-01-10","current":-6.228664,"twenty":-6.280824,"median":-6.044156,"eighty":-5.518409,"marketCap":91633187},{"date":"2025-01-17","current":-6.479118,"twenty":-6.381986,"median":-6.114998,"eighty":-5.51988,"marketCap":95317738},{"date":"2025-01-24","current":-6.827574,"twenty":-6.433383,"median":-6.156206,"eighty":-5.546995,"marketCap":100444070},{"date":"2025-01-31","current":-6.533564,"twenty":-6.529208,"median":-6.174218,"eighty":-5.650957,"marketCap":96118728},{"date":"2025-02-07","current":-6.424671,"twenty":-6.533564,"median":-6.22812,"eighty":-5.770729,"marketCap":94516749},{"date":"2025-02-14","current":-6.228664,"twenty":-6.533564,"median":-6.228664,"eighty":-5.853338,"marketCap":91633187},{"date":"2025-02-21","current":-6.860242,"twenty":-6.561876,"median":-6.283111,"eighty":-5.928174,"marketCap":100924664},{"date":"2025-02-28","current":-6.533564,"twenty":-6.583654,"median":-6.313396,"eighty":-5.93555,"marketCap":96118728},{"date":"2025-03-07","current":-5.83665,"twenty":-6.561876,"median":-6.313396,"eighty":-5.93555,"marketCap":85866063},{"date":"2025-03-14","current":-6.130661,"twenty":-6.544453,"median":-6.27751,"eighty":-5.928174,"marketCap":90191406},{"date":"2025-03-21","current":-6.043547,"twenty":-6.542275,"median":-6.261332,"eighty":-5.928174,"marketCap":88909823},{"date":"2025-03-28","current":-5.782204,"twenty":-6.533564,"median":-6.228664,"eighty":-5.862785,"marketCap":85065074},{"date":"2025-04-04","current":-5.461466,"twenty":-6.533564,"median":-6.206886,"eighty":-5.804122,"marketCap":79938742},{"date":"2025-04-11","current":-4.56399,"twenty":-6.533564,"median":-6.185107,"eighty":-5.723114,"marketCap":66802511},{"date":"2025-04-17","current":-4.651549,"twenty":-6.533564,"median":-6.172541,"eighty":-5.520861,"marketCap":68084094},{"date":"2025-04-25","current":-5.538079,"twenty":-6.522675,"median":-6.13409,"eighty":-5.512882,"marketCap":81060122},{"date":"2025-05-02","current":-6.545003,"twenty":-6.522675,"median":-6.114327,"eighty":-5.512882,"marketCap":95798326},{"date":"2025-05-09","current":-8.099168,"twenty":-6.533564,"median":-6.14155,"eighty":-5.51619,"marketCap":118546423},{"date":"2025-05-16","current":-7.453423,"twenty":-6.566232,"median":-6.174218,"eighty":-5.518409,"marketCap":109094749},{"date":"2025-05-23","current":-11.959073,"twenty":-6.642457,"median":-6.203155,"eighty":-5.518409,"marketCap":139211949},{"date":"2025-05-30","current":-13.885736,"twenty":-6.84282,"median":-6.227575,"eighty":-5.520371,"marketCap":161639650},{"date":"2025-06-06","current":-13.307738,"twenty":-6.982767,"median":-6.228664,"eighty":-5.534635,"marketCap":154911340},{"date":"2025-06-13","current":-13.218285,"twenty":-7.145541,"median":-6.27191,"eighty":-5.555592,"marketCap":153870054},{"date":"2025-06-20","current":-12.296239,"twenty":-7.475313,"median":-6.294194,"eighty":-5.575706,"marketCap":143136796},{"date":"2025-06-27","current":-12.674691,"twenty":-8.112302,"median":-6.314587,"eighty":-5.6646,"marketCap":147542238}],"updateTime":1751131855274}}}